why choose us

First received: April 28, 2023

Clinical Trial: Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Drug-induced Weight Gain

Study Type: INTERVENTIONAL


Official Title: A Randomized, Open-Label Study of the Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With the Atypical Antipsychotic Drug, Olanzapine

Brief Summary: This Phase 1b Study RDX-002-22-09 has been planned to evaluate the effect of RDX-002 on postprandial triglycerides and ApoB48 levels in normal healthy subjects treated with the atypical antipsychotic drug, olanzapine.

Read more